Skip to main content

Table 4 The association between NDC80 and LUAD clinical pathological features

From: Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development

parameters

NDC80

P value

–

+

Gender

P = 0.209

 male

45 (45.9%)

53 (54.1%)

 female

68 (54.4%)

57 (45.6%)

Age

P = 0.027

  <  60 years old

24 (39.3%)

37 (60.7%)

  ≥ 60 years old

82 (56.2%)

64 (43.8%)

Smoke

P = 0.002

 no

23 (65.7%)

12 (34.3%)

 Current smoker

15 (32.6%)

31 (67.4%)

 Smoker < 15 years

31 (44.9%)

38 (55.1%)

 Smoker ≥15 years

39 (59.1%)

27 (40.9%)

Stage

P = 0.032

 I

66 (57.4%)

49 (42.6%)

 II

23 (48.9%)

24 (51.1%)

 III

15 (31.9%)

32 (68.2%)

 IV

5 (55.6%)

4 (44.4%)

T

P = 0.199

 I

37 (61.7%)

23 (38.3%)

 II

63 (47.7%)

68 (52.3%)

 III

7 (41.2%)

10 (58.8%)

 IV

6 (40.0%)

9 (60.0%)

N

P = 0.053

 -

69 (56.6%)

53 (43.4%)

 +

44 (43.6%)

57 (56.4%)

M

P = 0.497

 -

81 (50.9%)

78 (49.1%)

 +

27 (45.8%)

31 (54.2%)